| Recruitment status | Suspended |
| Unique ID issued by UMIN | UMIN000042721 |
| Receipt No. | R000048760 |
| Scientific Title | Study on pathophysiology and clinical features of intractable and rare hepatobiliary and pancreatic disease and prognosis after treatment |
| Date of disclosure of the study information | 2025/03/31 |
| Last modified on | 2022/12/12 (Ver. 2) |
| Basic information | ||
| Public title | Study on pathophysiology and clinical features of intractable and rare hepatobiliary and pancreatic disease and prognosis after treatment | |
| Acronym | PBM | |
| Scientific Title | Study on pathophysiology and clinical features of intractable and rare hepatobiliary and pancreatic disease and prognosis after treatment | |
| Scientific Title:Acronym | PBM | |
| Region |
|
|
| Condition | |||
| Condition | Research in Progress | ||
| Classification by specialty |
|
||
| Classification by malignancy | Malignancy | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | Pathologically examine the effects of different confluent forms in PBM on the biliary epithelium |
| Basic objectives2 | Safety |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | clinical data and pathological samples of 24 patients were collected, and statistical and pathological studies have been completed. |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | PBM patients who underwent surgery at our hospital. | |||
| Key exclusion criteria | PBM patients who underwent surgery at another hospital. | |||
| Target sample size | 24 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Japanese Red Cross Society Wakayama Medical Center | ||||||
| Division name | pediatric surgery | ||||||
| Zip code | 6408558 | ||||||
| Address | 4-20 Komatsubara-dori, Wakayama | ||||||
| TEL | +81-73-422-4171 | ||||||
| masakihoriike1031@gmail.com | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Japanese Red Cross Society Wakayama Medical Center | ||||||
| Division name | pediatric surgery | ||||||
| Zip code | 6408558 | ||||||
| Address | 4-20 Komatsubara-dori, Wakayama | ||||||
| TEL | +81-73-422-4171 | ||||||
| Homepage URL | https://www.wakayama-med.jrc.or.jp/ | ||||||
| masakihoriike1031@gmail.com | |||||||
| Sponsor | |
| Institute | Osaka City University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Osaka City University |
| Organization | |
| Division | |
| Category of Funding Organization | Non profit foundation |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Japanese Red Cross Society Wakayama Medical Center |
| Address | 4-20 Komatsubara-dori, Wakayama |
| Tel | +81-73-422-4171 |
| masakihoriike1031@gmail.com | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Suspended | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Other | |
| Other related information | observational |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048760 |